Hester Biosciences to Divest 43.81% Stake in Subsidiary Texas Lifesciences Private Limited

Hester Biosciences Ltd. has announced its decision to divest 43.81% equity stake in its subsidiary, Texas Lifesciences Private Limited (TLPL). The decision was made during a Board meeting on 11th March 2026, following the recommendations of the Audit Committee. The stake will be transferred to the existing promoter shareholders of TLPL. TLPL is not a material subsidiary of Hester Biosciences and will cease to be a subsidiary upon completion of the share transfer transaction. The transaction is expected to be completed within three months from the date of the agreement, with a total aggregate value of INR 92 million. Hester Biosciences will continue to do business with TLPL promoter group and maintain an 11% equity stake in the company.